Business
Holding(s) in Company
Abingdon Health plc has been notified of changes in major shareholdings following a recent Placing and Retail Offer. Chris Yates, CatenaLucis LLC, and Thornapple LLP have each reduced their holdings to below 3% of the company's issued share capital, with previous holdings reported at 3.7%, 3.7%, and 3.2% respectively. These changes are due to an event changing the breakdown of voting rights. Disclaimer*
About this update from Abingdon Health Plc
[{"type":"text","content":"\n\n\n \nAbingdon Health plc\n(\"Abingdon Health\", the \"Group\" or the \"Company\")\n \nHoldings in Company\n \nYork, U.K. 2 December 2025: Abingdon Health plc (AIM: ABDX), a leading international developer, manufacturer and regulatory services provider for rapid tests and med-tech, has been made aware of the following changes in holdings of its ordinary shares of 0.025p each in the Company (\"Ordinary Shares\") following the recently completed Placing and Retail Offer:\n \n· Chris Yates, who holds an interest of 7,088,844 Ordinary Shares, now holds less than 3 per cent. of the Company's currently issued share capital.\n· CatenaLucis LLC, who hold an interest of 7,088,488 Ordinary Shares, now holds less than 3 per cent. of the Company's currently issued share capital.\n· Thornapple LLP, who holds an interest of 6,113,124 Ordinary Shares, now holds less than 3 per cent. of the Company's currently issued share capital.\n \nEnquiries:\n \n\n\n\n\n Abingdon Health plc\n\n\nwww.abingdonhealth.com/investors/\n\n\n\n\n Chris Hand, Executive Chairman\n\n\nVia Walbrook PR\n\n\n\n\n Tom Hayes, CFO\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Zeus (Sole Broker and Nominated Adviser)\n\n\n Tel: +44 (0)20 3829 5000\n\n\n\n\n Antonio Bossi / Jacob Walker (Corporate Finance)\n\n\n\n\n\n\n\n Nick Searle/Fraser Marshall (Corporate Broking)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Walbrook PR (Media & Investor Relations)\n\n\n Tel: +44 (0)20 7933 8780 or [email protected]\n\n\n\n\n Paul McManus / Alice Woodings\n\n\nMob: +44 (0)7980 541 893 / +44 (0)7407 804 654\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \nAbout Abingdon Health plc\nAbingdon Health Group is a leading med-tech contract service provider offering its services to an international customer base. \n \nThe Group's CDMO expertise offers lateral flow product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health has the int...